Target intelligence / Profile preview

Potassium voltage-gated channel subfamily A member 4 (KCNA4)

Target
KCNA4
Molecular classification
Ion channel, Voltage-gated potassium channel, Shaker-related potassium channel (Kv family)
01

Overview

Potassium voltage-gated channel subfamily A member 4 (KCNA4) is a tetrameric, voltage-gated potassium channel alpha-subunit belonging to the shaker-related (Kv) family, primarily forming rapidly inactivating A-type channels. These channels contribute to action potential repolarization and regulate membrane excitability in excitable cells such as neurons, cardiomyocytes, and muscle cells. By mediating potassium efflux following membrane depolarization, KCNA4 helps control the duration of action potentials, influences neurotransmitter release, and maintains normal cardiac rhythm. Genetic variants and dysfunction of KCNA4 have been implicated in rare neurodevelopmental and neuromuscular syndromes, as well as cardiac disorders. Pharmacological blockade of KCNA4—for example, by dalfampridine—prolongs action potentials and enhances synaptic transmission, an approach used therapeutically (e.g., in multiple sclerosis). However, such interference carries risks of seizures and arrhythmias due to the channel's critical physiological roles in both the nervous and cardiovascular systems

Other names
Kv1.4KCNA4LHK1HPCN2PCN2HUKIIHBK4Voltage-gated K(+) channel HuKIIVoltage-gated potassium channel HBK4Voltage-gated potassium channel HK1Voltage-gated potassium channel subunit Kv1.4Potassium channel 2Cardiac potassium channelFetal skeletal muscle potassium channelRapidly inactivating potassium channelShaker-related potassium channel Kv1.4Type A potassium channelMCIDDSKCNA8
02

Mechanism of action

Blockade of voltage-gated potassium channel to prolong action potential duration (notably by dalfampridine and 3,4-diaminopyridine)

03

Biological functions

Regulation of membrane potentialAction potential repolarizationRegulation of neurotransmitter releaseControl of heart rateNeuronal excitabilityRegulation of insulin secretionSmooth muscle contractionEpithelial electrolyte transportCell volume regulation
04

Disease associations

Cardiovascular diseaseNeurodegenerative diseaseEpisodic ataxia type 2MicrocephalyCataractsImpaired intellectual developmentDystonia with abnormal striatum
05

Safety considerations

May cause seizures or cardiac arrhythmias with antagonists or blockersrisk of neurotoxicity and off-target effects due to widespread expression in nervous and cardiac tissue
06

Interacting drugs

Dalfampridine (approved, antagonist)

2 more in the full profile.

Beyond the preview

Go deeper on Potassium voltage-gated channel subfamily A member 4 (KCNA4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium voltage-gated channel subfamily A member 4 (KCNA4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call